Article Information
History
- June 27, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- C. Patrick McClure1,2,6,*,
- Theocharis Tsoleridis1,2,3,
- Nadine Holmes2,4,
- Joseph G. Chappell1,2,
- Timothy Byaruhanga1,2,
- Joshua Duncan1,2,
- Miruna Tofan2,
- Abdul Khater2,
- Louise Berry5,
- Gemma Clark5,
- William L. Irving1,2,5,6,
- Alexander W. Tarr1,2,6,
- Jonathan K. Ball1,2,6,8,
- Stuart Astbury6,7,* and
- Matt Loose2,4,*
- 1Wolfson Centre for Global Virus Research, University of Nottingham, Nottingham, UK
- 2School of Life Sciences, University of Nottingham, Nottingham, UK
- 3The Pirbright Institute, Ash Road, Pirbright, Woking, UK
- 4Deep Seq, School of Life Sciences, University of Nottingham, Nottingham, UK
- 5Clinical Microbiology, Nottingham University Hospitals NHS Trust, Nottingham, UK
- 6National Institute for Health Research Nottingham Biomedical Research Centre, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK
- 7Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK
- 8Dept of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK
- ↵*Correspondence to: C. Patrick McClure Patrick.mcclure{at}nottingham.ac.uk, Stuart Astbury stuart.astbury{at}nottingham.ac.uk, Matt Loose matt.loose{at}nottingham.ac.uk
Posted June 27, 2024.
‘Vivaldi’: An amplicon-based whole genome sequencing method for the four seasonal human coronaviruses 229E, NL63, OC43 & HKU1, alongside SARS-CoV-2’
